Lecanemab: A hope in the management of Alzheimer's disease

被引：5
|
作者：
Thakkar, Nandita [1 ]
Martis, Preetham Basil [2 ]
Kutikuppala, L. V. Simhachalam [3 ]
Kuchana, Sai Kiran [4 ]
Mohapatra, Ranjan K. [5 ]
机构：
[1] Mahatma Gandhi Missions Inst Hlth Sci, Dept Gen Med, Navi Mumbai, Maharashtra, India
[2] Father Mullers Med Coll, Dept Gen Surg, Mangalore, Karnataka, India
[3] Dr NTR Univ Hlth Sci, Dept Gen Surg, Vijayawada 533201, Andhra Pradesh, India
[4] Kakatiya Med Coll, Dept Gen Med, Warangal, Telangana, India
[5] Govt Coll Engn, Dept Chem, Keonjhar, Odisha, India
来源：
BRAIN CIRCULATION | 2023年 / 9卷 / 03期
关键词：
D O I：
10.4103/bc.bc_10_23
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：194 / 195
页数：2
相关论文
共 50 条
  • [31] Alzheimer's disease and immunotherapy: hope or disillusion?
    Dubois, B.
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2006, 32 : S638 - S640
  • [32] Hope on the horizon for Alzheimer?s disease treatment?
    不详
    LANCET HEALTHY LONGEVITY, 2022, 3 (11): : E722 - E722
  • [33] Serotonin: A New Hope in Alzheimer's Disease?
    Claeysen, Sylvie
    Bockaert, Joel
    Giannoni, Patrizia
    ACS CHEMICAL NEUROSCIENCE, 2015, 6 (07): : 940 - 943
  • [34] Alzheimer's disease market: hope deferred
    Zelicia Gerald
    Waldemar Ockert
    Nature Reviews Drug Discovery, 2013, 12 : 19 - 20
  • [35] Alzheimer's disease market: hope deferred
    Gerald, Zelicia
    Ockert, Waldemar
    NATURE REVIEWS DRUG DISCOVERY, 2013, 12 (01) : 19 - 20
  • [36] Lecanemab Gains FDA Approval for Early Alzheimer Disease
    Larkin, Howard D. D.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (05): : 363 - 363
  • [37] Phyto-therapeutic and nanomedicinal approaches: A new hope for management of Alzheimer's disease
    Elzayat, Nourhan A.
    Abbas, Haidy
    Helmy, Maged W.
    Habib, Doaa A.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2022, 627
  • [38] The dawn of disease modification for Alzheimer's disease: Hope and peril
    Tan, Zaldy S.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2022, 70 (06) : 1661 - 1663
  • [39] Commentaries: Lecanemab: pioneering the way as the first approved drug for Alzheimer's disease treatment
    Zhang, Jinwei
    INFLAMMATION RESEARCH, 2023, 72 (09) : 1873 - 1876
  • [40] Commentaries: Lecanemab: pioneering the way as the first approved drug for Alzheimer’s disease treatment
    Jinwei Zhang
    Inflammation Research, 2023, 72 : 1873 - 1876
12345